By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Proteome Sciences today said that it will be performing biomarker analysis for a new European research initiative to study hypothermia as a treatment after stroke.
Ohio State University of Columbus, Ohio, has received US Patent No. 8,075,854, "Microfluidic chips for rapid multiplex ELISA. "The patent claims a microfluidic chip that consists of a substrate and a channel or multiple channels in the substrate.
The firm, Proteomedix Frontiers, has developed SRM-MS assays for more than 400 proteins that could be important to drug development efforts. It plans to offer them to pharma researchers both as kits and through agreements with contract research organizations.